Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, ...
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing. The ...
Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the "Company" or "Cannabix") and Omega Laboratories, ...
New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart ...
If you've noticed more picket signs outside hospitals this week, the labour dispute involving B.C.'s nurses is entering a new ...
Auxilium Biotechnologies today announced a major milestone in space biomanufacturing with the successful bioprinting of ...
A Peach, Love & Happiness festival will be held from 10 a.m. to 2 p.m. Saturday, July 11, at Cold Creek Nurseries, 398 ...
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...
SHELTON, CT / ACCESS Newswire / July 8, 2026 / NanoViricides, Inc. (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, reports that a Coverage Initiating ...
PRINCIPAL TECHNOLOGIES INC. (the "Company") announces that, further to its news release of June 3, 2026, the Company has closed its non-brokered private placement financing (the "Offering") with the ...
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results